Cargando…

Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses

Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid plaques and hyperphosphorylated tau in the brain. Currently, therapeutic agents targeting amyloid appear promising for AD, however, delivery to the CNS is limited due to the blood-brain-barrier (BBB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bathini, Praveen, Sun, Tao, Schenk, Mathias, Schilling, Stephan, McDannold, Nathan J., Lemere, Cynthia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313174/ https://www.ncbi.nlm.nih.gov/pubmed/35883506 http://dx.doi.org/10.3390/biom12070951

Ejemplares similares

“Non-thermal” ablation using focused ultrasound and an ultrasound contrast agent
por: McDannold, Nathan
Publicado: (2015)

Multiple sessions of liposomal doxorubicin and focused ultrasound mediated blood-brain barrier disruption: safety study
por: Aryal, Muna, et al.
Publicado: (2015)

Targeted and Reversible Blood-Retinal Barrier Disruption via Focused Ultrasound and Microbubbles
por: Park, Juyoung, et al.
Publicado: (2012)

BSCI-09. MECHANISMS OF ENHANCED DRUG DELIVERY IN BRAIN METASTASES WITH FOCUSED ULTRASOUND-INDUCED BLOOD-TUMOR BARRIER DISRUPTION
por: Ferraro, Gino, et al.
Publicado: (2019)

Disruption of Vascular Barriers in Tumors and in the Brain
por: McDannold, Nathan
Publicado: (2015)

Image guided focused ultrasound: development of a comprehensive treatment planning, monitoring and control, and assessment
por: Arvanitis, Costas, et al.
Publicado: (2015)

Elementwise approach for simulating transcranial MRI-guided focused ultrasound thermal ablation
por: McDannold, Nathan, et al.
Publicado: (2019)

Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles
por: Aryal, Muna, et al.
Publicado: (2017)

Low Intensity Focused Ultrasound for Epilepsy— A New Approach to Neuromodulation
por: Bubrick, Ellen J., et al.
Publicado: (2022)

Ultrasound-induced suppression of visually-evoked potentials: experience in nonhuman primates with a clinical transcranial MRI-guided focused ultrasound system
por: McDannold, Nathan, et al.
Publicado: (2015)

Targeted delivery of GABA via ultrasound-induced blood-brain barrier disruption blocks somatosensory-evoked potentials
por: McDannold, Nathan, et al.
Publicado: (2015)

Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system
por: McDannold, Nathan, et al.
Publicado: (2020)

Targeted Blood Brain Barrier Opening With Focused Ultrasound Induces Focal Macrophage/Microglial Activation in Experimental Autoimmune Encephalomyelitis
por: Schregel, Katharina, et al.
Publicado: (2021)

Controlled Ultrasound-Induced Blood-Brain Barrier Disruption Using Passive Acoustic Emissions Monitoring
por: Arvanitis, Costas D., et al.
Publicado: (2012)

Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model
por: McDannold, Nathan, et al.
Publicado: (2019)

Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy
por: Fischer, Krisztina, et al.
Publicado: (2015)

Magnetic Resonance Image Guided Focused Ultrasound Thalamotomy. A Single Center Experience With 160 Procedures
por: Lak, Asad M., et al.
Publicado: (2022)

Can ultrasound contrast agents increase the treatment envelope?
por: McDannold, Nathan, et al.
Publicado: (2015)

Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models
por: Raymond, Scott B., et al.
Publicado: (2008)

5th International Symposium on Therapeutic Ultrasound
por: Clement, G T, et al.
Publicado: (2006)

Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013)

Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
por: Antonios, Gregory, et al.
Publicado: (2015)

Longitudinal MR imaging after unilateral MR-guided focused ultrasound thalamotomy: clinical and radiological correlation
por: Blitz, Sarah E., et al.
Publicado: (2023)

Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
por: Thijssen, Elisabeth H., et al.
Publicado: (2021)

Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
por: Wirths, Oliver, et al.
Publicado: (2009)

Ultrasound‐mediated delivery of flexibility‐tunable polymer drug conjugates for treating glioblastoma
por: Sun, Tao, et al.
Publicado: (2022)

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
por: Petrushina, Irina, et al.
Publicado: (2008)

Nonthermal ablation of deep brain targets: A simulation study on a large animal model
por: Top, Can Barış, et al.
Publicado: (2016)

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
por: Bayer, Thomas A., et al.
Publicado: (2014)

Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice
por: Hoffmann, Torsten, et al.
Publicado: (2021)

Potential sources of interference on Abeta immunoassays in biological samples
por: Vanderstichele, Hugo, et al.
Publicado: (2012)

Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
por: Dietrich, Katharina, et al.
Publicado: (2018)

Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model
por: Catchpole, Ian, et al.
Publicado: (2013)

Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening
por: Ohta, Seiichi, et al.
Publicado: (2020)

Cavitation Feedback Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug Delivery in Patients with Parkinson’s Disease
por: Huang, Yuexi, et al.
Publicado: (2022)

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
por: Fuller, James P., et al.
Publicado: (2015)

Recent Advances on Ultrasound Contrast Agents for Blood-Brain Barrier Opening with Focused Ultrasound
por: Dauba, Ambre, et al.
Publicado: (2020)

Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
por: Lipsman, Nir, et al.
Publicado: (2018)

Magnetic resonance imaging–guided focused ultrasound thalamotomy for essential tremor: 5-year follow-up results
por: Cosgrove, G. Rees, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4v5ik8ntu3j22ernmrfhhuuti